Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: ELUSYS THERAPEUTICS INC
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2024-05-01 to 2028-12-31
Current total value of award: $124523123.01
Description: ANTHIM (OBILTOXAXIMAB)